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Abstract
Despite the presence of significant levels of systemic Interferon gamma (IFNc), the host protective cytokine, Kala-azar
patients display high parasite load with downregulated IFNc signaling in Leishmania donovani (LD) infected macrophages
(LD-MØs); the cause of such aberrant phenomenon is unknown. Here we reveal for the first time the mechanistic basis of
impaired IFNc signaling in parasitized murine macrophages. Our study clearly shows that in LD-MØs IFNc receptor (IFNcR)
expression and their ligand-affinity remained unaltered. The intracellular parasites did not pose any generalized defect in
LD-MØs as IL-10 mediated signal transducer and activator of transcription 3 (STAT3) phosphorylation remained unaltered
with respect to normal. Previously, we showed that LD-MØs are more fluid than normal MØs due to quenching of
membrane cholesterol. The decreased rigidity in LD-MØs was not due to parasite derived lipophosphoglycan (LPG) because
purified LPG failed to alter fluidity in normal MØs. IFNcR subunit 1 (IFNcR1) and subunit 2 (IFNcR2) colocalize in raft upon
IFNc stimulation of normal MØs, but this was absent in LD-MØs. Oddly enough, such association of IFNcR1 and IFNcR2
could be restored upon liposomal delivery of cholesterol as evident from the fluorescence resonance energy transfer (FRET)
experiment and co-immunoprecipitation studies. Furthermore, liposomal cholesterol treatment together with IFNc allowed
reassociation of signaling assembly (phospho-JAK1, JAK2 and STAT1) in LD-MØs, appropriate signaling, and subsequent
parasite killing. This effect was cholesterol specific because cholesterol analogue 4-cholestene-3-one failed to restore the
response. The presence of cholesterol binding motifs [(L/V)-X1–5-Y-X1–5-(R/K)] in the transmembrane domain of IFNcR1 was
also noted. The interaction of peptides representing this motif of IFNcR1 was studied with cholesterol-liposome and
analogue-liposome with difference of two orders of magnitude in respective affinity (KD:4 . 2 7 610
29 M versus
2.69610
27 M). These observations reinforce the importance of cholesterol in the regulation of function of IFNcR1 proteins.
This study clearly demonstrates that during its intracellular life-cycle LD perturbs IFNcR1 and IFNcR2 assembly and
subsequent ligand driven signaling by quenching MØ membrane cholesterol.
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Introduction
Visceral Leishmaniasis (VL), a potentially fatal visceralizing
disease, afflicts millions of people worldwide and is caused by
infection with Leishmania donovani (LD), an obligate-intracellular
trypanosomatid protozoan. During the past decades, a large body
of evidences supported the notion that the cytokine interferon
gamma (IFNc) plays a decisive role in anti-leishmanial defense
[1,2]. A primary defect that may lead to pathogenesis in VL is the
failure to activate parasitized macrophages (MØs) to eliminate LD
in response to IFNc [3]. Intriguingly, the presence of elevated
levels of serum IFNc in human VL [4–8] and high expression of
IFNc mRNA in lymphoid organs [9] do not reconcile with large
parasite burden observed at the active stage of the disease. The
remarkable predominance of the Th1 cytokine IFNc along with
impaired MØ effector function indicates a MØ specific desensi-
tization to the available IFNc stimulus. This was evident from
several in vitro studies [3,10,11] showing gross inhibition of the
IFNc signaling pathways in the LD infected MØs (LD-MØs), but
the exact mechanism that triggers the inhibition remained
unknown till date.
IFNc binds to specific cell surface receptor IFNcR which
consists of two heterodimeric subunits, IFNcR1 (a, ligand binding
subunit) and IFNcR2 (b, signal-transducing subunit). Signal
transduction of IFNc is initiated by its binding to IFNcR1 and
subsequent receptor subunit multimerization [12]. IFNcR1
colocalizes partly with the ganglioside GM1, a classical marker
of specialized cholesterol-rich membrane microdomains termed
lipid-rafts [13]. Subsequent evidences disclosed that membrane
lipid-rafts are intimately involved in the process of IFNc mediated
signal transduction. Remarkably, irrespective of various cell types
used in different reports, disruption of the plasma membrane rafts
by cholesterol depletion using methyl-b-cyclodextrin (mBCD) or
cholesterol sequestration with filipin reversibly affected not only
the generation of the IFNc inducible tyrosine phosphorylation of
signal transducer and activator of transcription 1 (STAT1) but also
productive transcriptional signaling [14–16]. This is congruent
with the prevalent hypothesis of lipid raft involvement in IFNc
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coupled receptors, transporters, or ion channels have been shown
to be localized or enriched in lipid rafts. The structure- activity
analysis shows that many of the cholesterol effects are due to
specific sterol-protein interactions as shown in case of a number of
membrane bound receptors such as those for cholecystokinin (type
B), oxytocin and nicotinic acetylcholine (nACh) [18]. Refined
structure of nACh receptor (nAChr) has been shown to have
internal sites capable of containing cholesterol, whose occupation
bolsters the protein structure [19]. Both oxytocin and serotonin1A
receptors contain the strict cholesterol consensus motif (CCC), and
in both the cases cholesterol incorporation lead to dramatic
increase in agonist affinity [20,21].
Previous studies from our group have shown that during their
intracellular life-cycle LD parasites disrupt the membrane rafts of
MØs by quenching cholesterol from the membrane. This was
associated with defective antigen presenting function, which could
be corrected by liposomal delivery cholesterol [22,23]. We also
showed that systemic administration of cholesterol through
liposomal delivery in LD infected hamsters has strong therapeutic
efficacy [23], in agreement with the clinical practice of using
cholesterol either directly [24] or as an adjunct to treatment [25].
It may be recalled that Kala-azar patients show progressive
decrease in serum cholesterol as a function of splenic parasite load
[26]. Therefore we investigated the potential involvement of LD
mediated manipulation of MØ membrane cholesterol in IFNc
signaling modulation.
Herein we report for the first time that the earliest activation
induced signaling event of IFNc receptor oligomerization is
inhibited due to quenching of the MØ membrane cholesterol by
the LD parasites. Restoration of the MØ membrane cholesterol by
exogenous delivery not only reinstates the receptor subunit
interaction but also restores subsequent downstream signaling as
well as the IFNc mediated leishmanicidal property.
Results
Defective IFNcR subunit multimerization in LD infected
MØs
Previous reports revealed that Leishmania spp. infected MØs are
refractory to exogenous IFNc mediated clearance of intracellular
parasites due to defective IFNc signaling [3, 11, 27, and 28]. In
this study, the molecular mechanism/s triggering the impairment
of IFNc signaling in LD-MØs have been investigated.
To investigate the mechanistic basis of defective IFNc signaling
in LD-MØs, BALB/c derived peritoneal MØs (PEC) and
homologous cell-line of RAW 264.7 were used. While performing
the preliminary experiments (Figure S1-S3), RAW 264.7 cells
yielded results comparable to the native system of PEC; therefore
all the subsequent experiments were performed using these cells
unless otherwise mentioned.
Of note, JAK2 phosphorylation, which is the proximal most
activation event down-stream to IFNcR1 engagement [12,29–32]
was uncoupled (Figure S3A), from the intact IFNc-IFNcR1
interaction in LD-MØs (Figure S2B). It has been reported that
ligand induced receptor multimerization is the crucial and
sufficient trigger for the activation of most of the cytokine
receptors [33–36], including IFNc receptors [37–41]. Thus, we
hypothesized that abrogation of earliest signal of JAK2 phosphor-
ylation by IFNcR1 engagement in LD-MØs most likely involve
the impairment of immediate upstream event of IFNcR subunit
multimerization.
To address this possibility, we utilized the fluorescence
resonance energy transfer (FRET) method, a powerful spectroflu-
orometric technique that has been used to determine molecular
interactions with higher resolution [42]. We assessed FRET
between cell surface IFNcR1 and IFNcR2 molecules that were
fluorescently labeled with receptor specific antibodies tagged with
DyLight488 or DyLight594 respectively. As shown in Figure 1A
(panel a), the emission spectrum excited with 485 nm light showed
reciprocal changes in donor emission peak (517 nm) versus
acceptor emission (620 nm), indicating that IFNc treatment
promoted energy transfer between IFNc-R1 and -R2 in normal
cells. In marked contrast, stimulation of LD infected cells with
IFNc could induce minimal or no FRET signal between IFNcR1
and IFNcR2 (Figure 1A, panel b and c). The FRET efficiency was
calculated in each of these conditions. As this was found to be low
in infected cells (E=0.166 in 4 hr and E=0.042 in 12 hr LD
infection) compared to that (E=0.465) of normal IFNc stimulated
condition, LD infection must have significantly inhibited ligand
induced receptor association. Thus the results indicate prominent
reduction in the ligand induced IFNcR1-IFNcR2 FRET efficien-
cy, which is reduced by 64.6 % at 4 hr and 90.9 % at 12 hr post
LD infection than the normal condition.
To confirm the observation, we coimmunoprecipitated IFNcR1
and IFNcR2 from ligand stimulated or unstimulated normal and
infected MØs. The results (Figure 1B) indicate that IFNc induced
copurification of the IFNcR2 subunits with IFNcR1 in normal
condition of the MØs. Conversely, infection for 4 hr markedly
reduced the extent of IFNcR2 coprecipitation with IFNcR1 even
in IFNc stimulated condition (Figure 1B), while the level of
coprecipitated IFNcR2 went below detection level with increasing
time of infection. Taken together, the results in this section imply
that LD infection inhibits IFNc induced receptor oligomerization
in MØs.
Ligand induced IFNcR subunit partitioning in detergent
resistant membrane fraction is lost in LD infected MØs
Association with lipid-raft membrane domains is known to
regulate the oligomerization of various cell surface receptors [43–
45]. It is also accepted that localization of the IFNcR complex
within intact lipid raft microdomains governs their efficient signal
transduction capability [14–16]. The aforementioned results
suggested that LD infection inhibits IFNc induced receptor
oligomerization in MØs, despite having unaltered initial ligand-
receptor association. We therefore speculated that differential
Author Summary
The disease Visceral Leishmaniasis or Kala-azar is extending
its base in the Indian subcontinent and elsewhere. The
emergence of drug resistant cases is aggravating the
problem further. The kala-azar patients do not respond to
the host-protective cytokine IFNc at the active stage of the
disease, the cause of which is unknown. This research is
designed to understand how cell surface receptors for IFNc
respond under parasitized condition. Our results clearly
showed that the Leishmania parasites during their
intracellular life-cycle make the host cell membrane fluid
by quenching cholesterol from the membrane, which
renders the IFNcR nonfunctional despite their physical
presence on the cell surface. Upon supplementation of
cholesterol in infected MØs, the infected cells regain
responsiveness to IFNc coupled with intracellular parasite
killing. Thus supplementation of cholesterol together with
IFNc may be a new approach to treat drug unresponsive
Kala-azar cases.
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IFNc-R1 and -R2 interaction. It was therefore necessary to
examine whether LD infection of the host cells delocalizes the
IFNcR chains from the lipid raft microdomains that in
consequence might hinder efficient oligomerization of the receptor
subunits upon IFNc mediated stimulation.
To study the abrogation of IFNc induced IFNcR subunits
partitioning, if any, under parasitized conditions, MØ membrane
extracts with 1% Triton X-100 were subjected to optiprep density
gradient separation and examined by immunoblotting to analyze
the distribution of IFNcR subunit proteins (Figure 2). Cholesterol-
rich lipid raft domains were characterized by the enrichment of
known raft marker protein flotillin1, while the fractions containing
the non-raft portions were identified with the surrogate marker of
transferrin receptor [46,22]. The success of the biochemical
isolation process was confirmed by determining the lipid raft
constituent glycosphingolipid GM1 in each fraction by dot blot.
Careful analysis of the fractionation study revealed that the
constitutive association of IFNcR1 with the detergent resistant
lipid raft fractions was discernibly disoriented at steady-state of the
early infected MØs where appreciable amount of IFNcR1 was
present in the detergent soluble fractions. Whereas, with increasing
severity of the LD infection, the IFNcR1 protein was nearly
completely delocalized from the lipid raft fractions and were
recovered from the detergent soluble higher density fractions
(Figure 2). On the contrary, the localization pattern of the IFNcR2
subunit showed a more or less diffused distribution throughout the
density gradients of the steady state of the normal MØs. Upon
IFNc mediated activation, the IFNcR2 subunit is recruited to the
lipid raft fractions almost to entirety which is accompanied by
Figure 1. IFNc induced IFNcR subunit association is impaired by LD infection. A, Fluorescence spectrometric analysis of IFNcR1-IFNcR2
FRET in uninfected and infected RAW 264.7 cells. Cells were treated with/without 100 U/ml of rIFNc for 3 minutes, washed with ice cold PBS,
transferred to ice and then fixed immediately. Cell-surface IFNcR1 and IFNcR2 were then stained with respective mAb linked directly to fluorophores,
Dylight488 (DL488) for anti-IFNcR1 and Dylight594 (DL594) for anti-IFNcR2. The fluorescence emission spectra in response to 485 nm excitation
before (solid black) and after (solid grey) IFNc treatment are shown with hashed black line representing the single stained Dylight488 control. ‘E’ in
the figures represents the FRET efficiency of IFNc treated samples, calculated as described in Materials and Methods. B, Immunoblot Analysis of
IFNcR1 and IFNcR2 in immunoprecipitates of anti-IFNcR1. IFNcR1was immunoprecipitated with either specific or control immunoglobulin from
uninfected and infected MØs stimulated with/without 100 U/ml of rIFNc for 3 minutes as described in Materials and Methods. Copurifying IFNcR2 was
detected by immunoblotting with anti-IFNcR2 (lower gel).
doi:10.1371/journal.ppat.1002229.g001
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mentioned energy transfer and coIP experiments (Figure 1).
Intriguingly, the IFNcR2 subunit distribution pattern was
markedly altered from the very early hours of infection through
the late hours, when bulk of the proteins were recovered from the
non-raft fractions, denoting complete detergent solubilization.
Nevertheless, at early hours of LD infection stimulation of the cells
with IFNc could elicit IFNcR2 redistribution albeit to a lesser
extent and this partial IFNcR2 recruitment to the raft domains
was reflected in concomitant decline in the efficiency of receptor
subunit interaction and signaling potency. Notably, at late hours of
LD infection, despite having simultaneous presence of both
IFNcR1 and IFNcR2 within the non-raft fractions, the IFNc
mediated stimulation of the MØs failed to induce any detectable
subunit interaction as evidenced by the absence of FRET or coIP
positivity at 12 hr postinfection.
The results were further validated in situ by confocal colocaliza-
tion study, which recapitulated the observations of the floatation
studies for the receptor distribution patterns. Analysis of the
colocalization pattern of the individual subunits of the IFNcR
assembly with the GM1 rich microdomains was quantified and
expressed in terms of the Pearson’s correlation coefficient (PCC)
values. The PCC values obtained by colocalization analysis of
constitutively raft associated IFNcR1 proteins with GM1 at the
steady state of the naı ¨ve MØs were considered as basal, and each
experimental condition assessed thereafter was represented as the
function of this optimal (100%) colocalization efficiency. The
results in Figure 3, demonstrate that the percentage colocalization
of IFNcR1 with GM1 molecules upon IFNc mediated activation
of the normal MØs remain unchanged (102%), signifying
preassociation of the IFNcR1 protein with the GM1 enriched
domain. The results also reveal that, there is a considerable
decrease in the percentage of colocalized IFNcR1 with GM1 in
the macrophage membrane at 4 hour post LD infection (71%)
than the basal condition. However, IFNc stimulation could elicit a
minor increase in the colocalization pattern (86.9%) sufficient to
elicit a partial activation of signaling cascade. With increasing time
of infection at 12 hr post infection, we observed a sharp decline in
the percentage of the colocalized IFNcR1 (32.7%) along with
absolute failure of IFNc to induce any detectable increase in the
colocalization pattern at this condition (34.2%).
Comparison of the percentage colocalization of the IFNcR2
with GM1 at the steady-state of the MØs showed a steep decline
both in the early as well as the late hours of LD infected MØs than
the uninfected control. In agreement with the floatation studies,
IFNc activation could elicit a partial increase in the colocalization
efficiency at the early hours of LD infection (62.5%), though
absence of the same at late hours of infection denotes a
conspicuous block in the IFNc triggered translocational behavior
of IFNcR2.
Impaired IFNc signaling complex formation under
parasitized condition
To investigate further, we stimulated the uninfected and LD
infected MØs with biotinylated IFNc and isolated the lipid rafts.
Total receptors and engaged receptors were immunoprecipitated
using anti-IFNcR1 and streptavidin-agarose respectively. The
activated forms of the signaling complex were determined by
resolubilization of the immunoprecipitates of streptavidin-aga-
rose, reprecipitation by p-Tyr antibody and immunoblotting with
antibodies against distinct components of the IFNc signaling
complex namely IFNcR1, JAK1, JAK2 and STAT1. As depicted
in Figure 4, endogenous IFNcR1 distribution was less affected
during early (4
th) hours of infection, but with increasing severity
of infection it was completely delocalized from the raft fractions.
Most striking of these results is that, though we could recover
some ligand engaged IFNcR1 from non-raft portions at 4 hr post
infection, IFNcR2 was only detectibly coimmunoprecipitated
from the raft fractions. Another significant finding of this
experiment was that though endogenous IFNcR1 and engaged
IFNcR1 could be immunoprecipitated from both raft and non-
raft fractions after 3 minutes of IFNc stimulation from 4 hr LD
infected macrophages, the phosphorylated (activated) IFNcR1
was only detected in the immunecomplexes from the raft
fractions along with other activated signaling intermediates. It is
worthy of note that at late hours of infection, though engaged
IFNcR1 (Figure 4) and IFNcR2 (Figure 2) were simultaneously
present in the non-raft fractions, they could not generate any
productive interaction as evidenced by the complete absence of
IFNc triggered CoIP and/or phosphorylation signal. These
results denote critical importance of cholesterol rich microenvi-
ronment for proper IFNcR functioning.
Figure 2. Disruption of lipid raft microdomains suppresses IFNcR subunit assembly in LD infected MØs. Uninfected and LD infected
MØs left untreated or treated with 100 U/ml of rIFNc (3 minutes, 37uC) were immediately washed with ice-cold PBS and crude membranes were
prepared which were then extracted with 1% Triton X-100 and subjected to optiprep density gradient centrifugation to isolate lipid rafts. Proteins
from equal volume of aliquots of the collected fractions were separated by SDS-PAGE and analyzed by western blotting using specific Ab against
IFNcR1, IFNcR2, Flotillin 1 and Transferrin receptor. To analyze the distribution of GM1, 2 ml of each fraction was dot blotted onto a nitrocellulose
membrane and detected using CTxB-HRP. ‘TfR’ denotes transferrin receptor for this and the subsequent experiments.
doi:10.1371/journal.ppat.1002229.g002
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receptor subunit interaction in LD infected MØs
involving differential raft partitioning of IFNcR subunits
The involvement of rafts in early IFNc signaling events such as
induction of STAT1 tyrosine phosphorylation has previously been
studied using methyl-ß-cyclodextrin (mBCD) as well as filipin and
nystatin [14–16], all of which perturb the raft integrity via
cholesterol depletion or sequestration [47]. Extending and
verifying our original observation of decreased MØ membrane
cholesterol in LD infected in vivo model [23], our in vitro system of
infected RAW 264.7 cells also showed reduction in membrane
cholesterol as function of time (Figure 5A), the kinetics of which
exactly coincided with the time points of waning IFNc signaling.
To clearly establish the role of cholesterol in IFNc mediated
receptor assembly, we replenished the LD-MØs with exogenous
cholesterol in liposomal form (CH-Liposome). Figure 5B shows
that cholesterol supplementation induced relocalization of
IFNcR1 within the raft domains regardless of the time points of
investigation after LD infection. Interestingly, in cholesterol
replete MØs, the engaged receptors were entirely recovered from
the raft fractions (Figure 6A). This cholesterol induced IFNcR1
relocalization was prominently associated with a marked increase
in IFNcR2 interaction, which was readily detected from the
immunecomplexes isolated by total IFNcR1 and/or engaged
IFNcR1 in the IFNc stimulated condition (Figure 6A). The
restored pattern of IFNcR subunit multimerization was more
conclusively verified in FRET experiments, where cholesterol
supplementation reinstated the IFNc inducible receptor subunit
interactions (Figure 6B).
To establish unambiguously the specific role of cholesterol in
influencing the earliest step of IFNcR signaling in reconstituted
membrane rafts of LD-MØs, we treated the infected MØs with
liposomes prepared with oxidized cholesterol analogue of 4-
cholestene-3-one (AN-Liposome). The results of coimmunopreci-
pitation (Figure 6A) and FRET (Figure 6B) analyses between
IFNcR subunits in AN-Liposome treated infected MØs showed
that treatment with AN-liposome failed to restore IFNcR
translocations as also the subunit interactions by IFNc stimulation.
In order to investigate whether the enhanced IFNcR oligomer-
ization in cholesterol-replete cells directly involves action of
cholesterol rather than its indirect effect via increased bulk
membrane rigidity, we treated LD-MØs with DPPC, a phospho-
lipid previously shown to induce increased membrane rigidity in
model membranes [48]. The data in Figure 5B, 6A reveal that in
contrast to cholesterol supplemented cells, the DPPC treated cells,
despite having comparable bulk membrane rigidity as indicated by
the FA values (Figure 6B, insets), failed to induce IFNc receptor
interaction indicating specific requirement of cholesterol in IFNcR
subunit assembly.
To corroborate the finding of cholesterol specific IFNcR
subunit interaction, RAW 264.7 cells were treated with mBCD,
which disrupts lipid rafts by specific depletion of cholesterol [49].
As shown in Figure 7A, stimulation of mBCD treated cells with
Figure 3. Confocal colocalization analysis of the IFNcR subunits in uninfected and LD infected macrophages. RAW 264.7 left untreated
or treated with 100 U/ml of rIFNc were stained with FITC-CTxB followed by either anti-IFNcR1 or anti-IFNcR2 followed by Fc specific secondary and
streptavidin-PE. The associated scatterplot represents the extent of colocalization of each experimental set, with inset showing the calculated
Pearson’s correlation coefficient (PCC) values. The percentage of colocalization was estimated as a function of the basal colocalization of IFNcR1
protein with the GM1 molecule in minimal invasive condition (without any manipulation of the steady-state condition of the naı ¨ve MØs). The values
under the column of % CoL denote the respective percent colocalization of individual protein with GM1 in the respective experimental conditions.
‘Sc’: Scatterplot.
doi:10.1371/journal.ppat.1002229.g003
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IFNcR1, which was found to be localized in the non-raft
membrane fractions. Comparable to the LD infected macrophag-
es, mBCD treatment completely abolished the activation of IFNc
signaling components while cholesterol replenishment of these
cells restored the subunit assembly (Figure 7) and activation
pattern of IFNc induction (Figure 7A). In additional control
experiments, conditions of mBCD treatments in RAW 264.7 cells
were first determined to ensure unaffected cell viability and
unaltered expression of surface IFNcR and components of STAT1
activation axis (data not shown).
LPG plays no role in delocalization of IFNcR from raft
LPG is a GPI anchored molecule secreted/shed by the parasites
after internalization in MØs by phagocytosis [50,51]. It is known
to increase the total membrane rigidity. Consistent with previous
reports [52–54], LPG induced significantly higher bulk membrane
rigidity upon incubation with MØs (Figure 8A) and was
incorporated substantially within GM1 enriched membrane
domains. However, it could not induce IFNcR1 delocalization
from the more buoyant lipid raft fractions as indicated by dot blot
analyses of individual membrane fractions of optiprep gradient
(Figure 8B). This intactness of IFNcR1 localization in the LPG
incubated MØs was also reflected in undiminished IFNc
functionality in these cells as assessed by the gamma activated
sequence driven luciferase (GAS-Luc) reporter system (Figure 8C),
a finding supported previously by Ray et al. [11]. Notably,
pharmacological depletion of membrane cholesterol from the
LPG-incubated MØs completely disoriented the IFNcR1 locali-
zation pattern and disrupted the membrane rafts as indicated by
the even distribution of GM1 molecules along the isolated density
gradients of the cell membrane (Figure 8B). Importantly, repletion
of cholesterol in the system of LPG-incubated mBCD-treated
MØs restored both the localization and functionality pattern of
IFNcR1 (Figure 8B, 8C).
As the infection in vivo propagates through amastigotes which
lack LPG [53], we asked the question if their role in IFNc signaling
inhibition was different from that of promastigotes. The result
depicted in Figure 9 demonstrates that for all the tested time points
of amastigote infection, deactivation of the IFNc signaling takes
place as early as 5 min post-IFNc stimulation. The result was
consistent with previous report [55] of immediate deactivation of
early IFNc signaling at the level of JAK2 phosphorylation in LD
amastigote infected primary human MØ, post 10 min of rIFNc
stimulation.
Collectively the above results strongly imply that membrane
cholesterol is critically involved in the initiation of IFNc signaling,
probably by direct modulation of IFNc receptor functionality.
Figure 4. Repression of IFNcR subunit assembly in disrupted lipid raft microdomains in LD infected MØs abrogates productive IFNc
signaling. Analysis of accumulation of the IFNc induced signaling complex in lipid rafts of RAW 264.7 cells. MØs were left uninfected or infected with
LD and stimulated with/without 0.5 ng/ml biotinylated IFNc for 3 min after the indicated time points of infection. Triton X-100 soluble non-raft (NR)
and insoluble lipid raft (R) fractions were isolated as described in figure 2. The fractions 2–4 were pooled to yield a total raft (R) compartment and
fractions 7–9 were pooled to obtain the non-raft (NR) compartment. Engaged receptors and their signaling complexes were immunoprecipitated
using Streptavidin-agarose beads. For comparison, the total amount of receptor was immunoprecipitated by adding anti-IFNcR1 Ab to the soluble
non-raft and raft fractions. Immunoprecipitates and corresponding total cell lysates were subjected to SDS-PAGE and immunoblotted using specific
Ab against IFNcR1 and IFNcR2. Activated forms of the signaling subunits were determined by dissociating the engaged signaling complexes pulled
down by Streptavidin-agarose beads, by boiling in 1% SDS, followed by immunoprecipitation using an anti-pTyr Ab. Activated and phosphorylated
proteins were analyzed by western blotting using Ab against IFNcR1, JAK2, JAK1 and STAT1. Equal loading was verified by immunoblotting of
respective whole proteins in whole cells lysates of each experimental set. Str: Streptavidin.
doi:10.1371/journal.ppat.1002229.g004
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preferential association with cholesterol
There are number of reports on the existence of a common
cholesterol recognition/interaction amino acid consensus (CRAC)
motif in various proteins [56] including several membrane proteins
that directly interact with cholesterol [57]. Very well characterized
CRAC motif conforms to the pattern (L/V)-X1-5-Y-X1-5-(R/K), in
which X1-5 represents between one to five residues of any amino
acid [56,57]. As an initial effort to explore the possibility that the
functionality of constitutively raft associated IFNcR1 protein is
directly modulated by the interaction of cholesterol, we tried to
detect the cholesterol recognition motif in it. Motif analysis of
IFNcR1 indeed identified two CRAC sites within the IFNcR1
subunit protein (Figure S4). Multiple sequence alignment showed it
to be highly conserved because the domain is present in many of the
homologous proteins in different species (Table S1) nullifying its
chance occurrence in murine IFNcR1. As denoted by Jamin et al.
theCRACmotifistypicallylocatedadjacenttoatransmembranea-
helix that positions this sequence within the nonpolar core of the
bilayer, where it can form contacts along the length of the
cholesterol molecule [58]. Sequence analysis of IFNcR1 predicted
the localization of the CRAC motif (2269 to 2280) within a
transmembrane a-helical portion (Figure S5). Accordingly, we
designed a peptide reproducing the CRAC motif of IFNcR1
protein (2269 to 2280) to analyze the binding of the motif with
cholesterol liposome. It should be noted that the tyrosine residue in
this motif has been shown by mutational analysis to be critical for
cholesterol binding in other proteins [58]. Therefore, another
peptide was designed to introduce substitution at positions 275 and
277to replacetyrosine,intended to disrupt/attenuate thebindingof
the peptide with cholesterol . We used surface plasmon resonance
(SPR) to examine the binding of IFNcR1 peptides to liposomal
formulation of cholesterol or its oxidized analogue 4-cholestene-3-
one. Binding of cholesterol to the Wt IFNcR1 peptide is indicated
by the high association rate (ka=2.69610
3 M
21 s
21) and affinity
(KD=4.27610
29 M) compared to those of the mutant
(ka=27 610
0 M
21 s
21,K D=3.77610
27 M). The specificity of
the cholesterol-IFNcR1 peptide interaction was also evident from
the 100 fold lower affinity of the Wt peptide for the cholesterol
analogue (Table 1 and Figure 10).
Enhancement of IFNc induced intracellular parasite
killing upon liposomal delivery of cholesterol in
parasitized MØ
We assessed whether cholesterol repletion could restore IFNc
induced leishmanicidal effects of the infected MØs. The results
depicted in Figure 11 reveal that IFNc stimulation of the
cholesterol repleted MØs mediated effective restoration of the
Figure 5. Membrane cholesterol influences the submembrane distribution of IFNcR subunits as well as IFNc induced receptor
subunit interaction and signaling efficacy in LD infected MØs. A, Analysis of membrane cholesterol of uninfected and infected MØs.
Cholesterol content in isolated membrane fractions was measured as indicated in Materials and Methods. The data represents mean 6 SD of triplicate
analyses. B, Restoration of IFNc inducible IFNcR subunit translocation in membrane rafts in cholesterol repleted LD infected MØs. LD infected MØs
left untreated or treated with Cholesterol-liposome (CH-Lipo) or 4-cholestene-3-one-liposome (AN-Lipo) or DPPC-liposome (DPPC-Lipo), were
stimulated with 100 U/ml of rIFNc (3 minutes, 37uC) at indicated timepoints postinfection, immediately washed with ice-cold PBS and subjected to
membrane harvestation. Membrane preparation and gradient fractions were done as described in figure 2. Equal volume of fractions from each
optiprep gradient were analyzed by western blotting by using antibodies to IFNcR1, IFNcR2, Flotillin 1 and Transferrin receptor (TfR) and GM1 dot
blots using CTxB-HRP.
doi:10.1371/journal.ppat.1002229.g005
Cholesterol and IFNc Signaling in Leishmaniasis
PLoS Pathogens | www.plospathogens.org 7 September 2011 | Volume 7 | Issue 9 | e1002229parasiticidal effects independently of the status of infection
progression. The data (Figure 11 A–C) showed 2.41 fold
(p=0.0003 vs infected control) and 2.16 fold (p,0.0001 vs
infected control) reduction respectively in the intracellular
amastigote number and percent of infected cells, when stimulated
by IFNc at 4 hr post infection, along with 2.51 fold (p=0.0009)
enhanced generation of NO. The observations of parasiticidal
effects and NO production were remarkably similar in MØs
stimulated with IFNc at later time points of infection (Figure 11 A’,
B’, C’), suggesting an effective reversal of the IFNc unresponsive-
ness of the infected MØs. As anticipated, AN-Liposome or DPPC-
Liposome treatment of the LD infected MØs failed to reinstate the
MØ responsiveness to IFNc stimulation.
To ascertain the direct correlation of cholesterol mediated IFNc
signaling with NO production and consequent leishmanicidal
effect without involvement of any secondary mediator, L-NMMA
was added to cholesterol treated cells. This indeed completely
abrogated the enhanced NO production and amastigote killing
potential of cholesterol replenished MØs in response to IFNc
(Figure 11 D, D’).
We finally assessed the generalized biological response of
cholesterol promoted IFNc signal enhancement in MØs. Analysis
of the IFNc induced transcriptional activity by GAS driven
luciferase reporter activity in cholesterol-supplemented systems of
CH-Liposome treated LD infected cells and mBCD treated cells
demonstrated enhanced bioactivity of IFNc, as manifested by
Figure 6. Analysis of raft association of steady-state and activated IFNcR signaling complex in LD infected and differentially treated
MØs. A, Immunoblot analysis of immunoprecipitates of isolated raft (R) and non-raft (NR) fractions from LD infected MØs left untreated or treated
with either Cholesterol-liposome (CH-Lipo) or 4-cholestene-3-one-liposome (AN-Lipo) or DPPC-liposome (DPPC-Lipo), and stimulated with 0.5 ng/ml
of biotinylated IFNc (3 minutes, 37uC) at indicated timepoints postinfection. Either anti-IFNcR1 or streptavidin-agarose beads were used for
precipitating immunocomplexes associated with total endogenous cell surface IFNcR1 or IFNc engaged IFNcR1 as described in details in Materials
and Methods. Activated forms of the signaling subunits were determined by resolubilizing the engaged signaling complexes followed by
immunoprecipitation using an anti-pTyr Ab. Activated and phosphorylated proteins were analyzed by western blotting using Ab against IFNcR1,
JAK2, JAK1, and STAT1. Immunoblotting of respective whole proteins in whole cells lysates of each experimental set verified equal loading. B,
Analysis of ligand inducible IFNcR subunit interaction in LD infected and differentially treated MØs. Fluorescence spectrometric assay of IFNcR1-
IFNcR2 FRET in infected RAW 264.7 cells left untreated or treated with Cholesterol-liposome (CH-Lipo) or 4-cholestene-3-one-liposome (AN-Lipo) or
DPPC-liposome (DPPC-Lipo). Cells were treated with/without 100 U/ml of rIFNc for 3 minutes at 37uC and washed and transferred to ice then fixed
immediately. FRET analyses were done exactly as described in figure legend 1A. Insets Measurements of fluorescence anisotropy (FA) value similarly
treated cells as in figure 6B. ‘E’ represents the FRET efficiency of IFNc treated samples, calculated as described in Materials and Methods.
doi:10.1371/journal.ppat.1002229.g006
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activation could be achieved by cholesterol treatment of deactivated
MØ systems.
Discussion
Our study reinforces the previous findings that LD-MØs are
refractory to IFNc mediated signaling, as evident from the
inability to clear intracellular parasites (Figure S1). This was due to
defective IFNc signaling as apparent from a number of functional
assays such as defective downstream signaling such as JAK2
phosphorylation (Figure S3A) and IFNc driven GAS-Luc activity
(Figure S3B) under parasitized condition. Interestingly enough, the
defect is not due to non-availability of IFNcR on the cell surface
(Figure S2A) or inability of the ligand to bind to the cognate
receptor as there was a comparable binding affinity (KD) in terms
of binding of
125I-IFNc between normal and infected conditions
(Figure S2B). It was also evident that LD-MØ did not show any
generalized defect as IL-10 mediated STAT3 phosphorylation
(Figure S3C) and internalization of
125I-IFNc remained unaffected
(Figure S2C).
Figure 7. Effect of pharmacological depletion of cholesterol from MØs on IFNc signaling and IFNcR subunit interaction. A, Analysis of
raft association of steady-state and activated IFNc signaling complex in mBCD treated and cholesterol repleted MØs. Confluent RAW 264.7 cells were
subjected or not (Control) to cholesterol depletion using 5 mM mBCD for 30 minutes at 37uC, and to cholesterol reloading using Cholesterol-
liposomes (CH-Lipo) (repletion). Following these treatments, cells were stimulated or not with 0.5 ng/ml of biotinylated IFNc for 3 minutes, 37uC,
before harvesting of cells. Total endogenous cell surface IFNcR1 and ligand engaged IFNcR1 were precipitated from pooled raft (R) (fractions 2–4) and
non-raft (NR) compartments (fractions 7–9) by anti-IFNcR1 or streptavidin-agarose beads as described in Materials and Methods. The immune
complexes were analyzed by Western blot using the appropriate antibodies against IFNcR1 and IFNcR2. Equal loading was verified by respective
whole protein immunoblotting from corresponding whole cell lysates. A sequential immunoprecipitation with pTyr antibody experiment from the
resolubilized immunecomplexes confirmed the activation status of the signaling subunits when blotted with antibodies against IFNcR1, JAK2, JAK1
and STAT1. B, FRET analysis of ligand induced IFNcR subunit interaction in mBCD treated and cholesterol repleted MØs. Fluorescence spectrometric
assay of IFNcR1-IFNcR2 FRET in RAW 264.7 cells that were either left untreated (Control) or subjected to cholesterol depletion or cholesterol reloading
of the depleted cells using Cholesterol-liposomes (CH-Lipo) (repletion). Cells were treated with/without 100 U/ml of rIFNc for 3 minutes, 37uC and
washed with ice cold PBS and transferred to ice then fixed immediately. FRET analyses were done exactly as described in figure legend 1A. Insets
Measurement of fluorescence anisotropy (FA) value of corresponding experimental RAW 264.7 cells treated with/without 100 U/ml of rIFNc. Data
represents mean 6 SD. ‘E’ represents the FRET efficiency of IFNc treated samples, calculated as described in Materials and Methods.
doi:10.1371/journal.ppat.1002229.g007
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PLoS Pathogens | www.plospathogens.org 9 September 2011 | Volume 7 | Issue 9 | e1002229Figure 8. Analysis of LPG-MØ interactions. A, Measurements of FA value of RAW 264.7 cells left untreated or treated with 10 mg/ml of purified
LPG for varying time periods. B, RAW 264.7 cells left untreated or treated with 10 mg/ml of purified LPG for 18 hrs (time equivalent of total parasite-
MØ interaction of 6 hrs of initial attachment and 12 hours of infection establishment) were subjected to membrane harvestation. Gradient fractions
were purified as described in figure 2. Equal volume of fractions from each optiprep gradient were analyzed by dot blot for the presence of GM1,
IFNcR1, LPG by using the appropriate antibodies and CTxB-HRP. C, IFNc induced bioactivity in LPG treated MØs was determined by reporter assay.
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multistep process which involves the binding of bivalent IFNc to
the extracellular domain of the cognate receptor subunit of
IFNcR1 in a ratio of 1:2 [59,60]. This provides the binding
scaffold for IFNcR2, the second subunit of the receptor complex
[61,62]. The receptor subunit assembly is unlikely to occur
randomly at the plasma membrane of the stimulated cells but is
confined to specific cholesterol rich membrane microdomains
termed rafts. This can be inferred from indirect evidences derived
by the use of cholesterol quenching drugs, which show
perturbation of IFNc signaling by depletion of membrane
cholesterol [14-16].
The defective IFNc signaling in LD-MØs was not due to LPG
because treatment of normal MØs with exogenous LPG showed
neither decrease in fluorescence anisotropy (FA) nor altered IFNc
mediated promoter activity (Figure 8). The defective signaling
induced by promastigote mediated infection could also be
reproduced with LPG deficient amastigotes (Figure 9); implying
that the effect is independent of LPG despite the intercalation of
LPG into membrane raft (Figure 8B and ref [54]) and increased
the total membrane rigidity (Figure 8A and ref [54]).
From the fractionation study (Figure 2) and confocal
microscopy (Figure 3), it was evident that IFNcR1 is raft
associated whereas IFNcR2 is largely non-raft associated. Upon
ligand driven stimulation, IFNcR2 moves to the raft fractions in
normal condition (Figure 2). During infection, restraint in
IFNcR2 recruitment in raft fraction even in the presence of
IFNc, suggests that the association of IFNc-R1 and -R2 in LD-
MØ is defective. This observation was further corroborated from
co-IP studies (Figure 1B) and confirmed by FRET analysis
(Figure 1A). An elegant study showed that the diffusion coefficient
of both GPI linked and native I-E
k are dependent on cholesterol
concentration [63]. Our study also showed that membrane
cholesterol decreases in LD-MØ as a function of time (Figure 5A).
Our results thus support the notion that the decreasing
membrane cholesterol due to the presence of intracellular
parasites affects the stimulation dependent mobility of IFNcR2
into rafts as shown in the case of T cell receptors at the plasma
membrane [64].
It was also observed that stimulation of normal MØs with IFNc
causes clustering of the entire IFNc signaling complex in the
membrane raft (Figure 4) which was absent under parasitized
condition. The effect caused by the intracellular parasites was
mimicked by quenching of cholesterol from the membrane by
mBCD and restored by liposomal delivery of cholesterol, as
evident from FRET analysis (Figure 7B) and fractionation studies
(Figure 7A). This observation indicates that intracellular parasites
may cause the above defects by quenching cholesterol from the
membrane. The specificity of cholesterol in inducing effective
IFNc inducible receptor interaction was assessed by supplemen-
tation of the LD-MØs with the oxidized cholesterol analogue 4-
cholestene-3-one (Figure 5B, 6A, 6B), which is known not to
induce lipid ordered domain or raft formation due to its head
group oxidation and differential partitioning behavior compared
to cholesterol [65,66,23]. The results imply that the oxidized
cholesterol analogue could not induce any productive interaction
between the receptor subunits of IFNcR1 and IFNcR2,
substantiating an obligatory role of cholesterol in maintaining
the functional integrity of IFNcR. The membrane packing of
cholesterol is supported by a hydrogen bond between the
cholesterol OH group and the amide bond of sphingolipids [49];
this interaction is presumably absent in the case of the oxidised
analogue because of the lack of OH group.
To assess whether increasing the membrane rigidity could restore
the propensity of IFNcR1 and IFNcR2 subunit interaction, we
supplemented the cell with DPPC-liposomes (Figure 5B, 6A, 6B) to
deliver saturated phospholipids, which increased the membrane
rigidity very efficiently. Intriguingly and paradoxically, the increased
membrane viscosity resulting from the delivery of DPPC (Figure 5,
6) or LPG (Figure 8), as evident from fluorescence anisotropy values,
was insufficient to potentiate IFNc induced receptor subunit
interaction. Collectively these results suggest a direct role of
cholesterol in stabilizing the IFNcR interactions, rather than an
indirect effect of bulk membrane rigidity to increase the chance
interaction of the receptor subunits by random proximity.
Membrane proteins such as G protein coupled receptors,
transporters, or ion channels have been shown to be localized or
enriched in lipid rafts. The role of cholesterol in receptor
RAW 264.7 cells were transfected with pCIS-CK negative control vector or IFNc driven pGAS reporter plasmid. 12 hrs after transfection, cells were
either left untreated or treated with mBCD (5 mM, 30 min, 37uC) and /or treated with 10 mg/ml of LPG for 18 hours. Treated cells were then
replenished or not with CH-Lipo. Subsequently treated cells were stimulated with or without 100 U/ml of rIFNc eight hours before final harvesting for
luciferase activity determination in cell lysates. The data represents the relative luciferase activity normalized to per microgram of protein content.
Data are representative of three independent experiments.
doi:10.1371/journal.ppat.1002229.g008
Figure 9. Suppression of IFNc signaling initiation in LD amastigote infected MØs. The MØs were infected with/without LD amastigotes for
indicated time periods as described in Material and Methods followed by treatment with 100 U/ml of rIFNc for varying time durations. Expressions of
phosphorylated STAT1 and whole STAT1 were measured in whole cell lysates via western blot using the same membrane. Equal loading was verified
by immunoblotting of actin.
doi:10.1371/journal.ppat.1002229.g009
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where stability of the active conformation of the receptors depends
on the presence of cholesterol with specific molecular interaction
between protein and adjacent cholesterol, such as cholecystokinin
(type B), oxytocin and nACh receptors [18]. nAChr is reportedly
shown to be stabilized in its activated form by a direct action of
cholesterol [19]. There are spectroscopic analyses showing that
variation in cholesterol concentration can perturb protein
secondary structure; this has been shown in photosystem II [67].
Because of nonavailability of pure IFNcR1 receptors (available
in the form of chimera with Fc receptor, which itself contains
cholesterol binding motif) we could not study the conformation
and determine kinetic values of IFNcR1 in association with
cholesterol-liposome/analogue-liposome.
Table 1. Summary of Binding parameters of IFNcR1 peptide-sterol interaction.
Sterol Peptide ka(1/M sec) kd (1/sec) KA (1/M) KD (M)
CHOLESTEROL Wt IFNcR1 2.69610
3 1.15610
25 2.34610
8 4.27610
29
Mutant IFNcR1 27.0610
0 1.02610
25 2.65610
6 3.77610
27
4-CHOLESTENE-3-ONE Wt IFNcR1 37.8610
0 1.02610
25 3.71610
6 2.69610
27
Mutant IFNcR1 35.7610
0 1.01610
0 3.53610
6 2.84610
27
Kinetic and affinity data from SPR analysis of the interaction between different IFNcR1 peptides and sterols. The binding parameters were obtained from global fit of the
curves for each experiment.
doi:10.1371/journal.ppat.1002229.t001
Figure 10. Binding analyses of specific IFNcR1 derived peptides to liposomal cholesterol and 4-cholestene-3-one by SPR.
A, Sensorgrams of peptide binding with liposomal formulation of cholesterol (a) wild type IFNcR1 peptide and (b) mutant peptide. B, Sensorgrams of
peptide binding with liposomal formulation of cholesterol analogue 4-cholestene-3-one (c) wild type IFNcR1 peptide and (d) mutant peptide.
Respective KD values obtained from global fit of all the graphs are denoted inside. Insets showing the concentrations of peptide used. The black
curves in all sensorgrams are the fitting curves using models from BIAevaluation 4.1. Data represents one of two repeat experiments.
doi:10.1371/journal.ppat.1002229.g010
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PLoS Pathogens | www.plospathogens.org 12 September 2011 | Volume 7 | Issue 9 | e1002229Figure 11. Cholesterol treatment restores IFNc induced leishmanicidal effects in LD-infected MØs despite prolonged infection.
Infected RAW 264.7 cells were left untreated or treated with CH-Lipo or AN-Lipo or DPPC-Lipo followed by stimulation with 100 U/ml of rIFNc for
24 hours at 4
th hour post infection (A, B, C)o r1 2
th hour post infection (A’, B’, C’) and the number of intracellular amastigotes per MØ, % infected
MØs and nitrite concentration (mM) were determined. Data are representative of three independent experiments. D, Pretreatment with inducible
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V)-X1-5-Y-X1-5-(R/K)] [57] in a number of membrane proteins,
the presence of such a motif in IFNcR was searched for. Sequence
analysis of IFNcR1 showed their presence in the transmembrane
domain. Kinetic studies revealed conspicuous interaction of such
motifs with cholesterol liposomes, but not with analogue
liposomes, which differed by two orders of magnitude (KD:
4.27610
29 M versus 2.69610
27 M; Figure 10). Consistent with
previous reports, the interaction is tyrosine dependent as the
tyrosine substituted peptide failed to interact with cholesterol since
the association rate was very slow and/or the affinity for
cholesterol was 100 fold reduced. These observations, thus clearly
denote that Leishmania parasites during their intracellular life cycle
by modulating membrane cholesterol, exert significant effect on
the IFNcR function with subsequent modification of IFNc
mediated intracellular parasite killing.
These results thus represent the first evidence of interaction of
cholesterol and cholesterol binding motif in IFNcR1. It corrob-
orates all the previous reports [14–16] of cholesterol dependent
IFNcR1 functional regulation. One would expect cholesterol-
liposome to show leishmanicidal effect in association with IFNc.
Indeed this study clearly showed such effect coupled with NO
generation in LD-MØs upon treatment with the above combina-
tion. The effect was cholesterol specific because the leishmanicidal
effect was not observed with analogue liposome or with DPCC-
liposome. This observation lends credence to our previous reports
showing strong therapeutic role of liposomal-cholesterol in
infected hamster model [23].
Survival strategy of the parasite LD might as well include
specific degradation and/or negative regulation of expression of
protein molecules of the infected cells such as STAT1 [68] and
IFNcR1 [69] - two important components of the IFNc signaling
pathway. The lack of reproducibility of these results in our system
is perhaps attributable to the difference in cell system or parasite
strains used for infection.
The mechanism by which LD modulates membrane cholesterol
is yet unknown. Given the fact that dynamic equilibrium between
the pools of free membrane cholesterol and cytoplasmic droplets of
cholesterol esters is very tightly controlled [70], diminished
membrane cholesterol in LD-MØs, may result from overall
decrease in total cellular cholesterol. It may be recalled that in VL
patients a progressive decline in serum cholesterol as a function of
splenic parasite load [26] is indicative of reduced cellular
cholesterol since serum cholesterol and total cellular cholesterol
are in dynamic equilibrium [71]. Interestingly, in L. major infected
macrophages decrease in cellular cholesterol is causally related to
reduced mRNA level of HMG-CoA reductase, the rate limiting
enzyme of cholesterol biosynthetic pathway [72]. Alternatively,
different reports [73,74] also suggest that LD may exploit host
cholesterol for its entry and survival, interfere with cholesterol
trafficking or may exchange host cholesterol for ergosterol, with
biophysical characteristics grossly different than cholesterol. Thus,
these contentions warrant further studies and are currently under
our investigation.
We would like to emphasize here that we have specifically dealt
with the earliest and critical most step of IFNc signaling occurring
within seconds (180 secs) of receptor ligation and demonstrate that
LD infection can efficiently impose a block at this step by specific
disruption of the receptor oligomerization by lowering the
macrophage membrane cholesterol level. It should be mentioned
here that IFNc signaling amplitude depends on the sustained
durability of the activation phenomenon and is very tightly
regulated by multiple negative regulatory mechanisms which
include dephosphorylation of the activated signaling intermediates
by inducible activity of phosphoprotein phosphatases [75], several
minutes after ligand–receptor interaction. Seminal study by
Blanchette et al. show that this basic physiological phenomenon
of signal duration restrain is efficiently utilized by the opportunistic
parasite Leishmania spp., to attenuate the IFNc signaling amplitude
[76] which in turn affect the overall IFNc bioactivity in LD
infected macrophages which likely contribute in part to the
inhibition of complete restoration of the IFNc signaling pattern in
cholesterol treated LD infected macrophages (Figure 11A, A’, B,
B’, C, C’, E).
Of note, constitutive SHP-1 preassociation with JAK2 in the
steady-state of normal cells as reported by various groups [77,78]
denotes an active repression of JAK2 autophosphorylation.
Experimental verification (Figure S6) denotes that in cholesterol
depleted systems with segregated IFNc receptor subunits as in
established LD infected macrophages, the SHP-1 species remained
associated with the JAK2 proteins, preventing its autophosphory-
lation upon ligand stimulation, which was in sharp contrast to
uninfected macrophages where the SHP-1 is released from JAK2
to induce its autophosphorylation within minutes (3 minutes) after
ligand stimulation. Interestingly, cholesterol supplementation in
LD infected cells reinstated the JAK2 activation profile and release
of SHP-1 from JAK2 immediately upon IFNc stimulation (our
unpublished observation, data not shown).
There is a report that Leishmania parasites deliver effector
proteins into host cells by exosome-based secretion and can
modulate host-cell function [79]. Thus it is not unlikely that
uninfected MØs in the infected splenic environment may trap
parasite derived antigen (s) and display similar defects in IFNc
signaling like infected MØs. It is worthy of mention that the late
established phase of VL is marked with increased production of
IL-10 [80]. IL-10, which has a prominent IFNc desensitizing role
acting directly at the level of STAT1 deactivation [81], might
account for the chronic infection in the presence of high
circulating IFNc in VL, providing an additional negative
regulatory step on IFNc signaling.
The central point that evolved from this study is that
intracellular LD quench membrane cholesterol; this in turn affects
nitric oxide synthase inhibitor blocks IFNc induced leishmanicidal effect in CH-Lipo treated infected MØs. RAW 264.7 cells were infected with LD at
m.o.i of 10, for 6 hours. MØs were then washed and either treated with CH-Lipo or left untreated as infected control. Subsequently, at indicated
timepoints postinfection, MØs were stimulated with or without 100 U/ml of rIFNc for 24 hours in presence or absence of 5 mM L-NMMA. Cell free
supernatant was harvested for NO measurement. Data of Nitrite concentration (mM) is representative of three independent experiments. The
amastigote numbers of the parallel sets treated similarly was demonstrated in D’. E, Enhanced IFNc-bioactivity in CH-Lipo replenished MØs as
determined by reporter assay. RAW 264.7 cells were transfected with pCIS-CK negative control vector or IFNc driven pGAS reporter plasmid. 12 hrs
after transfection, cells were either left untreated or treated with mBCD (5 mM, 30 min, 37uC) or infected with LD. Treated cells were then replenished
or not with CH-Lipo. Subsequently, mBCD treated cells with or without CH-Lipo reloading were stimulated with or without 100U/ml of rIFNc eight
hours before final harvesting for luciferase activity determination in cell lysates. While the infected cells with or without CH-Lipo treatment were
stimulated or not with 100 U/ml of rIFNc at indicated timepoints post infection. Eight hours later, luciferase activities in cell lysates were measured as
described in Materials and Methods. The data represents the relative luciferase activity normalized to per microgram of protein content. Data is
representative of three independent experiments.
doi:10.1371/journal.ppat.1002229.g011
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multimerization and subsequent downstream signaling in response
to IFNc. This defect could be corrected by exogenous delivery of
liposomal cholesterol leading to intracellular parasite clearance.
Based on this study, it can be reasonably speculated that
cholesterol may also influence the conformation of IFNcR1. Thus
in VL, cholesterol-liposomal formulation of IFNc treatment may
emerge as a promising therapeutic strategy both in drug-sensitive
and -resistant cases as it is directed specifically towards host than
the parasites.
Materials and Methods
Ethics statement
Use of mice was approved by the Institutional Animal Ethics
Committee of Indian Institute of Chemical Biology, India. All
animal experimentations were performed according to the
National Regulatory Guidelines issued by CPSEA (Committee
for the Purpose of Supervision of Experiments on Animals),
Ministry of Environment and Forest, Govt. of India.
Antibodies and other reagents
Anti-mouse IFNcR1 (MAB1026, Clone- 2E2.4) was obtained
from RnD systems, anti-mouse IFNcR2 (#559917, Clone- MOB-
47), biotinylated anti-rat IgG, biotinylated anti-hamster IgG,
Flottilin1, transferrin receptor (biotinylated CD71), antiSTAT1a,
Streptavidin-PE and recombinant mouse IFNc were purchased
from BD Pharmingen, San Jose, California. Anti-LPG antibody
(CLP003A, Clone- CA7AE) was from Cedarlane, Ontario,
Canada. FBS, RPMI 1640 medium, M199 medium, Penicillin-
streptomycin and sodium bicarbonate were obtained from
Invitrogen Life Technologies. Cholesterol, HEPES, 2-b ME (beta
mercaptoethanol), paraformaldehyde, ponceau S, FITC conjugat-
ed cholera toxin B subunit (CTxB-FITC), L-NMMA, 1, 6-
diphenyl-1, 3, 5-hexatriene (DPH) and Western Blocker Solution
for HRP detection systems were purchased from Sigma-Aldrich
(St. Louis, MO). Prestained protein molecular weight marker,
Bradford protein assay reagent and Laemmli buffer were from
Bio-Rad, Hercules, CA. Hybond ECL nitrocellulose membrane
and Hypercassette were from Amersham Biosciences. pJAK1,
pJAK2, p-Tyr were purchased from Santa Cruz Biotechnology.
JAK1, JAK2 (Santa Cruz Biotechnology) were kind gift from Dr.
Santu Bandyopadhyay, IICB (Kolkata, India). Streptavidin-HRP
was purchased from Zymed Laboratories. Phosphatidylcholine
(PC) (egg lecithin) and 1, 2-dipalmitoyl-sn-glycero-3-phosphocho-
line (DPPC) was from Avanti Polar Lipids, Inc., Alabaster,
Alabama and 4-cholestene-3-one was purchased from ICN (Irvine,
CA). All the amino acids were purchased from Novabiochem,
Merck. TFA, EDT, thioanisole, TIS were purchased from Merck,
Germany.
Parasite maintenance
LD strain AG83 (MHOM/IN/1983/AG83), originally ob-
tained from an Indian kala-azar patient [82], was maintained in
Golden hamsters as described previously [83]. Promastigotes
obtained after transforming amastigotes from the spleen of
infected animals were maintained in culture in Medium 199
supplemented with 10% FCS at 22uC. The culture was
replenished with fresh medium every 72 h.
Cell lines and preparation of peritoneal exudates cells
Murine MØ-like tumor cell, RAW 264.7 was obtained from
American Type Culture Collection. Cells were maintained in
complete medium at 37uC with 5% CO2 in a humidified
atmosphere.
BALB/c mice were obtained from the animal facility of the
institute and were housed under conventional conditions, with
food and water ad libitum. BALB/c mice were injected with 2 ml
of 4% starch i.p. The peritoneal cells (PEC) were harvested 2 days
after the starch injection and were rested for 24 h before any
treatments on these cells. In the meanwhile, the nonadherent cells
were washed out to generate pure adherent populations.
Infection of PECs and RAW 264.7
PEC and RAW 264.7 cells were allowed to adhere for 4 hr at
37uC in presence of a 5% CO2 atmosphere, after which the
nonadherent cells were removed by gentle washing with serum-
free medium. The adherent MØs, after overnight incubation in
complete medium, were challenged with LD promastigotes at a
MØ to parasite ratio of 1:10 and incubated further for 6 hr at
37uC. After initial attachment of 6 hr, excess parasites were
washed with serum-free medium, and this was considered as the
initial most (0 hr) time point of infection and the infection was
allowed to progress for the indicated time periods thereafter,
followed by rIFNc treatment with the suboptimal 10 U/ml,
optimal 100 U/ml and supraoptimal dose of 1000 U/ml. The
cultures were terminated after indicated timepoints and treat-
ments, by washing and immediate fixing with methanol, followed
by staining with Giemsa stain and counted under a light
microscope (Leica). The parasite load was expressed as the
number of amastigotes per MØ and % infected MØs as described
earlier [22]. In some experiments freshly prepared lesion derived
LD amastigotes were used for infection at a multiplicity of
infection (m.o.i) of 10. The dose of 100 U/ml of rIFNc was chosen
for optimum cell-activation as no additional benefit was obtained
for the higher dose tested.
Measurement of NO
Nitric oxide (NO) generation was monitored by using the Griess
reaction as described previously [84], and the results were
expressed in mM of nitrite accumulation. In some experiments,
MØs were cultured in the presence of N
G-monomethyl-L-arginine
(L-NMMA) a competitive inhibitor of inducible NO synthase,
added to a final concentration of 5 mM [85].
Flow cytometry
Membrane expression of IFNcR1 and IFNcR2 were investi-
gated on resting RAW 264.7 cells with incubation of 1610
6 cells
with anti-mouse IFNcR1 mAb or anti-mouse IFNcR2 mAb for
30 min at 4uC followed by two washes with cold PBS
supplemented with 1% FCS and 0.05% sodium azide (PBS-
azide). For secondary labeling, cells were stained with biotin-
conjugated anti-hamster antibody for 30 min at 4uC and were
washed twice with cold PBS-azide and were then labeled with PE-
conjugated Streptavidin. After the final wash with cold PBS-azide,
cells were fixed with cold 2% paraformaldehyde in PBS.
Membrane protein expression was analyzed with a FACSAria II
flow cytometer (Becton Dickinson, Mountain View, CA).
Radioiodinations and binding assays
Radioiodination of rIFNc was performed as previously
described [86]. rIFNc (5 mg at 0.5 mg/ml) was radioiodinated with
5 ml (500 mCi) of Na
125I (17 mCi/mg, BRIT, India) in the presence
of 25 ml of 0.15 M potassium buffer, pH 7.4, and 10 ml
chloramine-T (5 mg/ml) for 2 minutes. After neutralization of
the reaction with 10 ml each of sodium metabisulfite (10 mg/ml),
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mixture was chromatographed over a 10-ml Sephadex G-10
column equilibrated with a Tris/NaCl/BSA buffer (10 mM Tris-
HCl, pH 7.4, 0.15 M NaCl, and 0.33 mg/ml BSA). Fractions of
500 to 600 ml were collected, and the fraction containing the
greatest activity was used for receptor binding studies. The specific
activity of
125I-IFNc was 110 mCi/mg of protein. Anti-mouse
IFNcR1 (10 mg) was radioiodinated by following the method
essentially described in [87], with minor modifications. Briefly,
50 ml anti-mouse IFNcR1 was incubated with 25 ml (500 mCi)
Na
125I (17 mCi/mg, BRIT, India) in the presence of 125 mlo f
0.15 M potassium buffer, pH 7.4, and 50 ml chloramine-T (5 mg/
ml) for 4 min. The neutralization of the reaction was done as
above and readily sieved on a 10-ml Sephadex G-10 column.
Fractions of 400 ml were collected, and the fraction containing the
greatest activity was used for receptor binding studies. The specific
activity of
125I -labeled anti-IFNcR1 was in the range of 100–
105 mCi/mg of protein.
Saturation binding assays were performed as previously
described with brief modifications [10]. To enumerate receptor
numbers,
125I-IFNc was added to final concentrations of 5–
800 pM to 2610
7 cells per ml of RPMI medium containing 2%
fetal bovine serum in duplicates. After 180 min of incubation at
4uC, cells were washed thoroughly with ice cold PBS. The
radioactivities associated with separated cell pellet and the
supernatant were quantified in a scintillation counter (Packard)
to determine free and bound
125I-IFNc respectively. To determine
nonspecific binding, the amount of
125I-IFNc bound to the cells in
the presence of a 200-fold excess of unlabeled ligand was
determined. Specific binding was calculated by subtracting
nonspecific binding from the total radioactivity bound. After
correcting for nonspecific binding, data of
125I-IFNc saturation
binding experiments were fitted to a one-site binding hyperbola
and analyzed with non-linear regression analysis to determine KD
and Bmax values using GraphPad Prism 5.0 (GraphPad, San
Diego, USA) to obtain parameters of equilibrium binding, where
Bmax denotes the maximal density of receptor sites and KD
denotes the radioligand equilibrium dissociation constant. In
addition,
125I-IFNc saturation binding data were displayed using
Scatchard plots where the X-axis is specific binding (Bound) and
the Y-axis is specific binding divided by free radioligand
concentration (Bound/Free) [88].
Ligand dependent and independent internalization assay
125I-labeled murine IFNc and
125I-labeled anti-mouse IFNcR1
were used respectively to determine the ligand induced and
constitutive bulk flow endocytosis mediated IFNcR internalization
and were performed as previously described [11,89] with minor
modifications. For internalization studies, 2610
6 cells were
replenished with ice-cold RPMI containing 2% fetal calf serum.
Parallel wells received either
125I-labeled IFNc or
125I-labeled anti-
mouse IFNcR1 and were incubated for 180 minutes in 4uC, after
which unbound radioactivity was removed with brief wash with ice
cold PBS and incubations were continued in 37uC medium
without ligand to allow internalization to occur. At intervals
thereafter, cells were immediately added with ice cold PBS and
transferred to ice, to stop internalization. Membrane-associated
ligand or antibody was removed from the cells with low pH acid
wash buffer (0.2 M acetic acid, 0.5 M NaC1, pH 2.5, [90]).
Internalized ligand or antibody was determined by solubilization
of the acid-treated cells in 1 M NaOH. Radioactivity was
measured with a scintillation counter (Packard). The amount of
radioactivity remaining with cells that had been kept at 4uC all
along before acid treatment was taken to represent ‘nonspecific’
acid-resistant radioactivity and was subtracted from the values
obtained from the 37uC incubations to provide an estimate of
specific ligand internalization. The data were fitted to linear
regression analysis program in GraphPad Prism 5.0 (GraphPad,
San Diego, USA) to obtain the rate of internalization by following
the methods of Liu et al. [91].
Cell lysis and western blotting from whole cell lysates
Cell lysis and western blotting were carried as described
previously [92] with fewer modifications. In general, uninfected
or LD infected RAW 264.7 cells were treated with or without
100 U/ml of rIFNc for 3 min, 37uC. After washing twice with ice-
cold PBS, cells were lysed in 1X RIPA Buffer from Cell signaling
technology, Danvers, MA (20 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium
deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM beta-
glycerophosphate, 1 mM Na3VO4,1 mg/ml leupeptin, with
recommended addition of 1 mM PMSF immediately before use).
In some experiments, cells were treated with 10 ng/ml of rIL-10
for 15 min, 37uC [93]. Protein concentration was determined
using the Micro BCA protein assay kit (Pierce Chemical Co.
Rockland, IL). Proteins (20 mg/lane) were separated by SDS-
PAGE on a 10% gel under reducing conditions and electro-
transferred to nitrocellulose membranes (HYBOND ECL, Amer-
sham, Piscataway, NJ) in a transfer buffer consisting of 20 mM
Tris-HCl, 150 mM glycine, and 20% methanol. Membranes were
incubated at 4uC overnight in blocking buffer (Western Blocker
Solution, Sigma). Primary and secondary Abs were diluted as
recommended by the manufacturer in blocking buffer and
incubated with the membranes for 1 hr, at room temperature
with five washes in between, with wash buffer (20 mM Tris,
500 mM NaCl, pH 7.4). Detection of HRP-conjugated Abs was
performed using SuperSignal West Pico Chemiluminescent
Substrate (Pierce, Rockland, IL).
Transfection and transient expression of luciferase
reporter gene constructs
Interferon gamma driven luciferase reporter activity was
essentially done as in ref. [94]. RAW 264.7 cells were transfected
with the pGAS cis-reporter plasmids or the pCIS-CK negative
control plasmid by electroporation [95] by Genepulser X cell
(Bio-Rad, Hercules, CA). Cells from three electroporations were
pooled to eliminate differences between individual transfections
and the mixture was then equally divided among the wells of a
24-well cluster dish (Corning CoStar Corp., Cambridge, MA).
They were next allowed to adhere to the substratum for 4 hr
before the medium was changed. After 24 hr (which was needed
to reduce the background levels of luminescence), the medium
was again changed and were either infected with LD or left
uninfected. After the initial attachment of the parasites with the
cells for 6 hr, the cells were washed and the infection was allowed
to progress for the indicated time periods. Thereafter, cultures
were incubated for 8 hr with medium alone or medium that
contained 100 U/ml IFNc. The cells were harvested in 300 mlo f
passive lysis buffer (Promega Biotech, Madison, WI), and 50 ml
aliquots of the clarified extracts were used to assay luciferase
activity using Luciferase assay kits/reagents from Promega
Biotech according to the manufacturer’s protocols. Luciferase
activity was normalized to the levels of the protein content. The
average is reported along with the standard deviation of the
mean. The pGAS cis-reporter plasmid and the pCIS-CK
negative control plasmid were purchased from Stratagene, La
Jolla, CA.
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Unilamellar liposomes were prepared from PC with either
cholesterol or an analogue of cholesterol (4-cholesten-3-one) at a
molar ratio of 1:1.5 as described in ref. 22, 23. For liposome
preparation with DPPC, we followed the methods of Giraud et al.
[96]. DPPC (13.8 mg) was dissolved in a chloroform-methanol (9:1
v/v) mixture. The solvent was removed by evaporation under
vacuum, followed by overnight drying of the resulting film under
vacuum to remove the residual solvents. The dry film of DPPC
was rehydrated in PBS, pH 7.4, then alternately heated in a water
bath at 60uC and mixed via a vortex mixer at room temperature
for 5 min to allow full hydration of the phospholipid and finally
sonicated using an ultrasound 2 mm tip in microprobe sonicator.
According to the conventional procedure, repetitive 30-sec cycles
of sonication/ice cooling were performed. Samples were briefly
centrifuged to remove titanium particles.
FRET analysis and DyLight labeling of primary antibodies
For fluorescence resonance experiments, anti-mouse IFNcR1
and anti-mouse IFNcR2 were conjugated to DyLight488 or
DyLight594 (Pierce; N-hydroxy succinimide (NHS) ester-activated
fluorescent dyes) respectively, according to the manufacturer’s
protocol. Naı ¨ve or infected MØs were stimulated with/without
IFNc for 3 min, 37uC to induce FRET signals. The stimulation
was terminated by immediate transfer of cells to ice and washing
with ice-cold PBS. The cells were then fixed with 2%
paraformaldehyde/PBS at 4uC. After washing the paraformalde-
hyde and quenching the excess formaldehyde for 15 min with
0.1% NaBH4 in PBS, staining was followed with excess antibodies
to respective IFNcR subunits at 4uC, for 1 hr. Following 3 washes
with cold buffer, cells were resuspended in PBS. Spectroscopic
analysis of cells in a quartz cuvette was done with to 485 nm
excitation and recording the emission spectra from 500 nm to
700 nm with emission and excitation slit of 2.5 nm. FRET
efficiency (E) was obtained from the measured fluorescence
intensity of the donor (Dylight488- IFNcR1) at its maximal
emission wavelength (519 nm) in the presence and absence of the
acceptor (Dylight594- IFNcR2) using the equation with E (%) =
(1 – Ida/Id), where Ida and Id are the fluorescence intensities in the
presence and absence of acceptor, respectively [97,98].
Co-Immunoprecipitation and immunoblotting
For co-immunoprecipitation, experimental cells, treated as
indicated in the figure legends, were aspirated off the medium
and washed with ice cold PBS, lysed in Cell Lysis Buffer (1X), Cell
signaling technology (20 mM Tris pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4,
1 mg/ml Leupeptin with 1 mM PMSF added immediately prior
to use). After 10 min on ice, lysates were collected by scraping,
sonicated for 15 s (0.3 s bursts), centrifuged at 10, 000 r.p.m. for
10 min at 4uC and the supernatant was recovered. Total protein
concentrations were determined using the Micro BCA protein
assay kit (Pierce Chemical Co.) with BSA as standard. Lysates
were pre-cleared using Protein A/G plus Agarose beads (Pierce
Chemical Co.). 200 ml of precleared supernatants were incubated
overnight at 4uC with specific primary Ab to IFNcR1 or control
unrelated whole rabbit IgG, and the immune complexes were
collected on 20 ml of 50% bead slurry Protein A/G Plus-Agarose
(prewashed and preblocked with 2% BSA for 2 hour, at 4uCi n
25 mM Tris, 150 mM NaCl; pH 7.2) for 2 h, at 4uC, with gentle
shaking. Precipitates were washed 5 times with 500 ml of 1X Cell
Lysis Buffer, kept on ice during washes and microcentrifuged for
60 seconds at 4uC at 2500 x g, each time. The pellet was
resuspended with 20 ml of 2X Laemmli sample buffer [(Bio-Rad,
Hercules, CA), 62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2%
SDS, 0.01% Bromophenol Blue, 5% b-mercaptoethanol], vortex-
ed for 30 seconds and boiled for 5 min before resolving in SDS-
PAGE gels and probed with antibodies as detailed in the figure
legends and detected as previously stated.
Analysis of membrane fractions on floatation gradients
Total crude cell membranes were isolated as described in ref.
[99]. Cells were homogenized in 1 ml of buffer [10 mM Tris-HCl
(pH 7.4), 1 mM EDTA, 200 mM sucrose] and protease inhibitor
mix (Roche Diagnostics, Mannheim, Germany)]. The nuclei and
cellular debris were removed by centrifugation at 900 x g for
10 min at 4uC. The resulting supernatant was centrifuged at
110,000 x g for 75 min at 4uC to obtain the crude membrane
pellet. Purification method of detergent-soluble and -insoluble
fractions was adapted from ref. [100], with very few modifications.
The crude membrane pellet was solubilized in 1 ml of Lysis buffer
(Caveolae/ Rafts Isolation Kit, Sigma) containing 1% Triton X-
100 and was agitated end to end for 30 min at 4uC. The sample
was mixed with OptiPrep and to a final OptiPrep concentration of
35%. Then the density gradient was made of 5 layers of OptiPrep
with 35, 30, 25, 20, and 0%. The volume of each layer was 2 ml
except for 1 ml of 0% OptiPrep. Samples were centrifuged at
200,000 x g for 4 h at 4uC. After centrifugation, nine fractions of
1-ml from the top to bottom of the ultracentrifuge tube were
collected. As described in manufacturer’s instruction, caveolin-1
positive fractions were found in fractions 2–4 (25–35% OptiPrep)
counting from the top (data not shown), which were also enriched
in GM1 content. Ganglioside GM1 was visualized with an HRP-
conjugated cholera toxin B subunit (1:2000, Sigma) in dot blots
with 2 ml sample from each gradient fraction. In some experi-
ments, fractions 2–4 or fractions 7–9 were combined, and are
referred to as Triton-insoluble glycolipid enriched membranes
(rafts) or Triton-soluble (non-raft) fractions, respectively. Equal
volumes (50 ml) of each fraction were analyzed directly by western
blotting.
Confocal microscopy, image processing and quantitation
of signal overlap on fixed cells
Experimental cells were grown on glass-coverslips and treated
as indicated in figure legends and after final treatment, washed
with cold wash buffer. Cells, preblocked in ice cold blocking
buffer (1X PBS with 2 % FBS) for 30 minutes in 4uCw e r e
stained with anti-mouse IFNcR1 or anti-mouse IFNcR2 in
blocking buffer diluted to a predetermined optimal concentra-
tion and incubated at 4uC in the dark. The reaction was stopped
by adding ice cold wash buffer and washed three times. For
staining with secondary Ab, biotin-conjugated Fc specific anti-
I g Gw a sa d d e da n ds t a i n e da sd e s c r i b e da b o v ea n df o l l o w e db y
streptavidin-PE. The cells were counterstained with FITC-
CTxB following the protocol described above. The cells were
then fixed with 1% paraformaldehyde, mounted with 90%
glycerol on a glass slide, and observed under a laser scanning
microscope [Leica (Mannheim, Germany) TCS SP2 AOBS
system] by using a 63 oil-immersion objective. Double-stained
images were obtained by sequential scanning for each channel
to eliminate the ‘‘cross-talk’’ of chromophores and to ensure
reliable quantification of colocalization [101]. Images were
acquired and processed for colocalization analysis in TIFF
format. Colocalization was estimated using Pearson’s correla-
tion coefficient [102] analyzed by ImageJ software (rsbweb.
nih.gov/ij/).
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raft and non-raft fractions
Total IFNcR1 or engaged IFNcR1 were immunoprecipitated
from pooled ‘rafts’ fraction (2, 3 and 4) and the ‘non-raft’ fraction
(7, 8 and 9) as described previously [103,104] with minor
modifications of both. Cells were stimulated for 3 minutes at
37uC with biotinylated rIFN-c [Recombinant murine IFN-c was
conjugated to EZ linked N-hydroxysulfosuccinimide-biotin
(Pierce, Rockford, IL) according to the manufacturer’s instruction.
Cells were incubated with 0.5 ng/ml biotin-conjugated IFNc,
which is the calculated approximate equivalence to 100 U/ml of
bioactive unconjugated IFNc in our system and gave unaltered
stimulation index in terms of STAT1 phosphorylation and pGAS-
Luc activity in supportive experiments as with the unconjugated
rIFNc (data not shown)]. Stimulation was terminated by
immediate washing with ice cold PBS and harvesting cells in lysis
buffers. To immunoprecipitate total amount of IFNcR1 from
isolated raft and non-raft fractions, 0.5 ml of the pooled raft and
non-raft fractions were added to 0.5 ml of cell lysis buffer, were
pre-cleared, and the signaling complex was immunoprecipitated
overnight at 4uC with anti-IFNcR1 (10 mg/ml) and the recovery of
the pulled immunecomplex was done exactly as described before.
Alternatively, engaged IFNcR1 were immunoprecipitated from
pooled raft and non-raft fractions with streptavidin-agarose beads.
Pooled ‘rafts’ fraction (2, 3 and 4) and the ‘non-raft’ fraction (7, 8
and 9) pre-cleared of non-specific binding proteins by incubation
with 50 ml of agarose beads (prewashed and suspended to 50% in
1X cell lysis buffer). Pre-cleared lysates were incubated with
streptavidin-agarose beads (50 ml of even suspension of 50% bead
slurry ) for 2 hr at 4uC with gentle end over end shaking, washed
using our immunoprecipitation protocol and procured from the
beads and analyzed as before. Control experiments confirmed that
no proteins bound to streptavidin-agarose beads if cells were left
untreated with biotinylated IFNc (data not shown). Where
indicated, the IFNc signaling complex pulled down by immobi-
lized streptavidin-agarose was dissociated in 50 ml of PBS
containing 1% SDS by boiling for 10 min and diluted 20-fold
with lysis buffer before it was subjected to a second immunopre-
cipitation using 10 mg/ml of an anti-pTyr Ab. The washing,
procurement and immunoblot analysis were done exactly as
mentioned before.
Methyl b-cyclodextrin (mBCD) treatment of cells
For some experiments, cells were treated with mBCD (Sigma-
Aldrich, St. Louis, MO) to disrupt lipid rafts. In the initial set of
experiments, cells were treated with different concentration of
mBCD ranging from 2 to 20 mM in the absence of serum for
30 min at 37uC, after which cell viability was assessed by trypan
blue exclusion and the cell membrane cholesterol content and the
cell-membrane fluidity were measured (data not shown). Only
conditions that allowed for cell viability comparable to mock
treatment were used for these studies. It was observed that RAW
264.7 cells maintained the ability to exclude vital dyes such as
trypan blue after treatment with 5 mM mBCD though treatment
with the same essentially caused an acute depletion of cholesterol
content from the cell membrane almost equivalent to the
conditions of prevailing in MØ with 12 hr LD infection.
Measurement of fluorescence anisotropy (FA)
The membrane fluorescence and lipid fluidity of cells were
measured following the method described by Shinitzky and Inbar
[105]. Briefly, the fluorescent probe DPH was dissolved in
tetrahydrofuran at 2 mM concentration. To 10 ml of rapidly
stirring PBS (pH 7.2), 2 mM DPH solution was added. For
labeling, 10
6 cells were mixed with an equal volume of DPH in
PBS (Cf 1 mM) and incubated for 2 hr at 37uC. Thereafter the
cells were washed thrice and resuspended in PBS. The DPH
probe bound to the membrane of the cell was excited at 365 nm
and the intensity of emission was recorded at 430 nm in a
spectrofluorometer. The FA value was calculated using the
equation: FA = [(II -I H)/ (II + 2I H)], where II and I H are the
fluorescent intensities oriented, respectively, parallel and perpen-
dicular to the direction of polarization of the exciting light
[106,22].
Measurement of cholesterol content
Sample for cholesterol estimation was essentially prepared
following the methods described in ref [107]. The crude plasma
membrane fraction was isolated as described above from the
experimental cells and suspended in a minimum volume of PBS.
An aliquot was used for protein measurement. The rest of the
pellet was extracted with 2:1 methanol/chloroform, followed by
0.5 ml of chloroform and 0.5 ml of water. The methanol/
chloroform (lipid phase) layer was dried under vacuum. The dry
lipid was suspended in 200 ml of 1X Reaction buffer provided in
Amplex Red Cholesterol Assay Kit (Molecular Probes’ Invitrogen)
and membrane cholesterol quantitation was performed exactly
according to manufacturer’s instructions.
Interaction of purified LPG with MØs
A method modified from ref. [108] was employed. Lyophilized
lipophosphoglycan (LPG), purified from LD (a kind gift from Prof
SJ Turco, University of Kentucky, Lexington, USA), was
solubilized in double–distilled water to 1 mM stock and frozen
in 220uC as aliquots. Stock solution was diluted in PBS and added
to the MØ cultures to a final concentration of 10 mg/ml and was
incubated at 37uCi n5 %C O 2 and high humidity for indicated
time duration, in each experiment. The cells were washed three
times in cell–culture medium with 5% FCS at room temperature
to remove unbound LPG followed by washing three times in PBS
at 4uC to terminate the experiment.
Peptide synthesis and purification
Sequence analysis of IFNcR1 protein was done with
ScanProsite software (EXPASY TOOLS) to find out consensus
motif for cholesterol binding and the peptides were designed
accordingly. Peptide designed and synthesized from wild type
IFNcR1 protein, reproducing cholesterol binding motif (CRAC
motif, residues 2269 to 2280) was designated as Wt IFNcR1
peptide (269- VILVFAYWYTKK-). Point mutant IFNcR1
peptide (269- VILVFAAWATKK-) reproduces the tyrosine to
alanine substituted form of Wt IFNcR1 peptide. The peptides
were synthesized on Rink Amide MBHA resin using standard
solid phase Fmoc chemistry [109] with a capping step with 5%
acetic anhydride and 5% lutidine in DMF after each coupling
using PS3 peptide synthesizer (Protein Technologies Inc, USA).
Fmoc-amino acids were activated with HBTU in presence of
HOBt and DIEA. Peptides were cleaved from the resin and side-
chain protecting groups were removed by incubating with 94%
TFA, 2.5% EDT, 1.5% thioanisole, 1.5% water, 0.5% TIS for
3 hrs at room temperature after which peptides were precipitated
with ice-cold diethyl ether. Peptides were then purified by HPLC
(Waters, USA) on a reverse phase mbondapak C-18 column using
0–80% acetonitrile in 0.01% TFA and molecular weight
determined by MALDI-TOF/TOF analyzer (Applied Biosystem,
USA).
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Binding experiments were done by surface plasmon resonance
(SPR) as described [110], on a BIAcore 3000 system (Biacore AB,
Piscataway, NJ). L1 sensor chip (Biacore) with hydrophobically
modified dextran layer was used to for SPR experiment to study
binding of peptide to immobilized liposomes. Freshly prepared
liposome were immobilized on L1 sensor chip up to response unit
of 2000–2500 at flow rate of 5 ml/min in PBS (pH=7.2). To
remove any multilamellar structures from the lipid surface, we
injected NaOH (50 ml, 10 mM) at a flow rate of 50 ml /min, which
resulted in a stable baseline corresponding to the lipid monolayer
linked to the chip surface. The negative control BSA was injected
(25 ml, 0.1 mg/ml in PBS) to confirm complete coverage of the
nonspecific binding sites. After complete association required
dissociation time was given to wash loosely bound liposomes and
to achieve stable base line. Kinetic experiments were performed
with serial dilution of the peptides. Concentration of the peptides
used were 0.02 nM, 0.2 nM, 2 nM, 20 nM, 200 nM in PBS
(pH=7.2). Peptides binding measured by observing the change in
SPR angle as 90 ml of peptide analyte flowed over the immobilized
liposome for 3 min at flow rate 30 ml/min. L1 sensor chip was
regenerated using 200 ml of 20 mM CHAPS at flow rate of 50 ml/
min. Different dilutions of protein samples in buffer were injected
at a flow rate of 30 ml/min. The response was monitored as a
function of time (sensorgram) at 25uC. SPR experiments were
conducted in duplicate at each concentration to confirm the
bindings were repeatable. Multiconcentration data were globally
fit, and residuals were calculated and used to assess the goodness of
fit with BIAevaluation 4.1 software (Biacore, Piscataway, NJ).
Statistical variation and presentation
Each experiment was performed thrice, and representative data
from one set of these experiments are presented; the interassay
variation was within 10%. Two-tailed Student’s t test was
performed to ascertain the significance of the differences between
the means of the control and the experimental groups. We
considered values of P,0.05 to be statistically significant. P value
,0.001 were considered extremely significant (***), P value
ranging between 0.001 to 0.01 were very significant (**), P value
0.01 to 0.05 as significant (*) and P value .0.05 were not
significant (ns) (Student’s t test). Error bars indicate mean 6 SD.
Data was analyzed by using Prism 5.0 (GraphPad, San Diego,
CA).
Supporting Information
Figure S1 Loss of IFNc response in MØs from very early
time point of LD infection. A, Monolayers of freshly plated
and adhered mPEC (A and B) and RAW 264.7 (D and E) were
either left untreated or exposed to promastigotes of Leishmania
donovani at a multiplicity of infection (m.o.i) 10:1. After initial
attachment of 6 hr, excess parasites were washed and the infection
was allowed to progress for the indicated time periods, followed by
rIFNc treatment with suboptimal 10 U/ml, optimal 100 U/ml
and supraoptimal 1000 U/ml doses for 24 h. The intracellular
parasite number was expressed as amastigotes per MØ and
percentage infected cells in the culture. C and F, Culture
supernatants from MØs treated exactly as in A–E were harvested
and assayed for Nitrite concentration (mM) by Griess reaction as
described in Materials and Methods. The results shown are from one
of three identical experiments which yielded similar results, and
represent the mean 6 SD of triplicate determinations for each
experimental group.
(TIF)
Figure S2 Unaltered endogenous cell surface IFNcR
expression, ligand binding and ligand induced receptor
internalization kinetics in LD infected MØs. A, Flow
cytometric analysis of surface expression of IFNcR1 and IFNcR2
in RAW 264.7 cell that were left uninfected or infected with LD at
a m.o.i of 10 for indicated time periods. Numbers in the plot
indicate the mean fluorescence intensity. B, Non-linear regression
analysis of the binding of IFNc to the IFNcR protein in normal
and LD infected MØs. Uninfected and infected MØs were treated
with increasing concentrations of trace labeled 125I- IFNc for 3 hr
at 4uC in the presence or absence of 200 fold excess of cold IFNc.
Scatchard plots (insets) and KD and Bmax values were obtained
using the Graph Pad Prism program by analyzing data for specific
IFNc binding. Data represents the mean of duplicate measure-
ments for each concentration of IFNc. C, Rate of ligand induced
IFNcR internalization in uninfected and infected RAW 264.7.
Cells left uninfected or infected for 4 hr or 12 hr with LD were
treated with
125I- IFNc (100 U/ml) for 3 hr at 4uC followed by
incubation at 37uC for various time intervals. At the end of
incubation, cells were rinsed twice with ice cold PBS and then
treated with a low pH buffer (pH 2.5) for 5 minutes at 4uC that
removes surface-bound ligand. The acid-inaccessible internalized
ligand is presented as a fraction of total cell-associated radioactivity
prior to cell transfer to 37uC. For control, we tested the behavior of
steady-state internalization of IFNcR by labeling them with
125I-
IFNcR1 antibody for each experimental set tested. The constitu-
tive and inducible internalization rate was shown in inset and
calculated by linear regression analysis in Graph Pad Prism.
(TIF)
Figure S3 Suppression of IFNc signaling initiation in LD
infected MØs. A, The MØs were infected with/without LD
promastigotes for indicated time periods as described earlier,
followed by treatment with 100 U/ml of rIFNc for 3 min.
Expressions of phosphorylated JAK2 and whole JAK2 were
measured in whole cell lysates via western blot using the same
membrane.Densitometricreadingsrepresent the ratio ofintensity of
phosphorylated JAK2 (pJAK2) to JAK2 protein expression per unit
area and are represented as arbitrary units (au). Equal loading was
verified by immunoblotting of cytoplasmic actin. B, RAW 264.7
cells were transfected with either pGAS-Luc or the pCIS-CK
negative control plasmid. After 12 hr of transfection, cells were
eitherleftuninfectedorinfectedwithLDandatindicated timepoints
postinfection cells were treated with 100 U/ml rIFNc for 8 hrs,
before final harvestation. Cell lysates were prepared, and luciferase
assay was done as described under Materials and Methods. Medium
control denotes the transfected cells without any subsequent
treatments. The values shown in all panels are the average of
triplicate measurements in a single experiment and are expressed as
relative light units (RLU) normalized to total protein content in each
sample. C, Assessment of the unrelated JAK-STAT pathway by IL-
10 sensitization of LD infected MØs. The MØs were left uninfected
or infected with LD promastigotes for indicated time periods as
described earlier, followed by treatment with 10 ng/ml of rIL-10 for
15 minutes. Expressions of phosphorylated STAT3 and STAT3
were measured in whole cell lysates via western blot using the same
membrane. Equal loading was verified by immunoblotting of actin.
(TIF)
Figure S4 Scanprosite analysis of mouse IFNcR1 pro-
tein sequence (Accession: EDL03452.1 GI: 148671505)
denoting the CRAC motifs. Two CRAC motifs in IFNcR1
protein sequence located within amino acid position 2269 to
2280 and 2393 to 2399 are highlighted in yellow.
(TIF)
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mouse IFNcR1 protein sequence (Accession: EDL03452.1
GI: 148671505). The predicted a-helical portion of IFNcR1
protein sequence is denoted as letter ‘H’ in red.
(TIF)
Figure S6 SHP-1 forms a constitutive complex with
JAK2 in macrophages and the release of SHP-1 is IFNc
inducible. The MØs were infected with/without LD promasti-
gotes for 12 hrs as described earlier, followed by treatment with
100 U/ml of rIFNc for 3 minutes. Cells were then treated with/
without cell permeable crosslinker of DSS, as per manufacture’s
protocol (Pierce). After cell lysis, protein extracts was immuno-
precipitated with anti-JAK2. To verify the identity of JAK2 and
SHP-1, immunoprecipitates were separated on polyacrylamide-
SDS gel, and immunoblotting was performed with anti-JAK2
antibody or anti-SHP-1 antibody.
(TIF)
Table S1 Identification of the cholesterol recognition /
interacting amino acid consensus pattern. Alignment of
amino acid sequences showing presence of CRAC motif
conforming to -L/V-(X)1–5-Y-(X)1–5-R/K- in IFNcR1 proteins
in different species.
(DOC)
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